All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY269 | Anti-GYG1 (3B5) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Rat | 3B5 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY270 | Anti-GYG1 (CBLG1-2154) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2154 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY271 | Anti-GYG1 (CBLG1-284) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-284 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY272 | Anti-GYG1 (2C10) h(41BB-CD3ζ) CAR, pCDCAR1 | 2C10 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY273 | Anti-GYG1 (CBLG1-2155) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2155 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY274 | Anti-GYG1 (CBLG1-2156) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Rat | CBLG1-2156 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1909 | Anti-GYG1(3B5) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Rat | 3B5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1910 | Anti-GYG1(CBLG1-2154) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2154 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1911 | Anti-GYG1(CBLG1-284) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-284 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1912 | Anti-GYG1(2C10) h(CD28-CD3ζ) CAR, pCDCAR1 | 2C10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY1913 | Anti-GYG1(CBLG1-2155) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2155 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1914 | Anti-GYG1(CBLG1-2156) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Rat | CBLG1-2156 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION